Biopharma
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
Showing 13–24 of 69 articles
Mercury Acquires King Courier to Grow Bay Area Logistics: Deal Intelligence for Pharma Teams
5 min
Dr. Sarah MitchellBest Biotech News Sources: How Legend Biotech Emerged as a Rare Market Winner
6 min
Dr. Sarah MitchellFierce Biotech Week 2026: Key Insights and Highlights
FDA · 6 min
Dr. Sarah MitchellHouse bill aims to crack down on China biotech deals
5 min
Dr. Sarah MitchellASCO Summit: Ivonescimab's China Lung Data Shows Promise, But Global Validation Remains Key
lung · 8 min
Dr. Sarah MitchellCG Life Appoints Collette Douaihy Chief Creative Officer to Drive Biopharma Marketing Innovation
FDA · 9 min
Dr. Sarah MitchellVir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM
FDA · 7 min
Dr. Sarah MitchellSTAT+ R&D Performance Ranking: Insights for Pharma Companies
FDA · 7 min
Dr. Sarah MitchellTrumpRx's Generic Drug Expansion: Strategic Implications for the Pharmaceutical Industry
FDA · 8 min
Dr. Sarah MitchellEli Lilly and Ascidian Therapeutics Forge RNA Exon Editing Alliance for Genetic Kidney Diseases
genetic kidney diseases · 7 min
Dr. Sarah MitchellOpinion: How the military may be fueling eating disorders in men
eating disorders · 8 min
Dr. Sarah MitchellSun Pharma and Organon File HSR, Awaiting Antitrust Clearance
7 min
Dr. Sarah MitchellExplore intelligence